KLH in Clinical Trials

Clinical trials involving KLH. Details such as study status, design and investigators are available by link to outside sites.

Clinical trial links are intended for informational purposes only, and are not solicitations for any study nor provided for the purposes of giving medical advice. See Terms of Use for this site.

(in order by date)

Entries in Healthy Volunteers (7)

Monday
Jan302017

2017-000084-32

Wednesday
Oct122016

NCT02947854

Study to Assess Safety, Tolerability and Immune Response of Fimaporfin-induced Photochemical Internalisation of Antigen/Adjuvant

An Open-label, Phase I/Proof of Principle, Dose Escalation Study to Assess Safety, Tolerability and Immune Response of Fimaporfin-induced Photochemical Internalisation (PCI) of Antigen/Adjuvant in Healthy Male/Female Subjects

Condition: Healthy Volunteers
Sponsor: PCI Biotech
Phase 1 


Friday
May202016

NCT02800811

Safety, Tolerability, PK, PD, and Immunogenicity of Single and Multiple Ascending Intravenous Doses of FR104

First-in-human, phase I, randomized, double-blind, placebo-controlled, single center study evaluating single and multiple ascending intravenous doses of FR104 in healthy subjects.

Condition: Healthy Volunteers
Sponsor: OSE Immunotherapeutics
Phase 1 

Relates to J Immunol. 2016 Dec 15;197(12):4593-4602. Epub 2016 Nov 14.

Tuesday
Mar042014

NCT02079480

Study to Evaluate the Safety, Tolerability, PK, and PD of CD40 in Healthy Subjects (CD40 FIH)

Condition: n/a  (Healthy Adults)
Sponsor: Bristol-Myers Squibb
Phase I

Monday
Jun042012

2011-001232-27

Thursday
Dec012011

NCT01489956

A Study to Determine the Immunogenicity and Oral Tolerance to Keyhole Limpet Hemocyanin (KLH)

Conditions: Autoimmune Disorders
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID) 
Phase 0 completed

Sunday
Dec062009

NCT01027780

Mindfulness to Improve Elders' Immune and Health Status

Conditions: Stress, Psychologic
Sponsors: Univeristy of Rochester, National Institute on Aging (NIA)
Phase n/a